EC approves Mundipharma’s Neulasta biosimilar Pelmeg for neutropenia
Pelmeg EU approval : The European Commission (EC) has approved German pharma company Mundipharma’s Pelmeg, a pegylated version of granulocyte-colony
Continue readingCoverage of Global Pharma Industry News
Pelmeg EU approval : The European Commission (EC) has approved German pharma company Mundipharma’s Pelmeg, a pegylated version of granulocyte-colony
Continue readingLuxturna EU approval for inherited retinal disease : Pennsylvania-based Spark Therapeutics has bagged the European Commission’s (EC) approval for its
Continue readingArmas Pharmaceuticals has launched its first injectable to the US market in the form of Azacitidine for Injection 100 MG,
Continue readingPromacta FDA approval : The US Food and Drug Administration (FDA) has approved a label expansion for Novartis’ Promacta (eltrombopag)
Continue readingPharma acquisition news : Brooklyn Immuno Therapeutics, a newly formed pharma company focused on developing for cytokine-based therapies for cancers,
Continue readingAdcetris FDA approval : Seattle Genetics has secured new approval from the US Food and Drug Administration (FDA) for its
Continue readingAemcolo FDA approval : Cosmo Technologies has bagged approval from the US Food and Drug Administration (FDA) for its antibacterial
Continue reading4D Molecular Therapeutics (4DMT), a California-based gene therapy company, has secured orphan drug designation for 4D-110 from the US Food
Continue readingNefecon phase 3 trial : Calliditas Therapeutics has initiated a phase 3 clinical trial called NEFIGARD to evaluate its lead
Continue readingHumacyl vascular trauma trial : Humacyte, a regenerative medical technology company, has started a phase 2 clinical trial of its
Continue reading